Anti-Amyloid-beta Immunotherapy in Alzheimer's Disease: ACC-001 Clinical Trials Are Ongoing

ArticleinJournal of Alzheimer's disease: JAD 17(2):243 · July 2009with18 Reads
Impact Factor: 4.15 · DOI: 10.3233/JAD-2009-1118 · Source: PubMed